1 yıllık getiri (CAGR)
53.29%
Johnson & Johnson Exchange (NYSE, USD)
JNJ
271.22
+1.51 (+0.56%)
HealthcareDrug Manufacturers - General
Loading...
3 yıllık getiri (CAGR)
18.61%
5 yıllık getiri (CAGR)
10.38%
10 yıllık getiri (CAGR)
8.67%
Objective Corporation Hisse Senedi Analizi – Eyalet İçinde Eyalet
Daha fazla okuPiyasa değeri
652.31B
Fiyat/Satış
6.66
Ent değeri
747.98B
Fiyat/Defter
7.68
DIV kazancı
1.98%
Büyüme yılları
58
DIV büyümesi
5.25%
FCF ödemesi
95.35%
Trailing P/E
31.01
PEG
4.84
İleri P/E
21.79
EPS büyümesi
14.90%
İş anlayişi
Temel Analizin Anlamı ve Metodolojisi (2025)
Daha fazla okuSegment Revenues ($M)
Loading...
Operations comments
In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission
The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021
Geographic Revenues ($M)
Loading...